Bonk vs Cbdmd
Cbdmd is the larger business, with $19.2m of revenue in fiscal 2025 against $2.1m for Bonk (9.1 times as much). Bonk grew faster (201.6% against -1.5%). Cbdmd kept more of each dollar of sales as profit: a net margin of -10.6% against -3220.4%.
| Latest fiscal year | BonkBNKK, 2025 | CbdmdYCBD, 2025 |
|---|---|---|
| Revenue | $2.1m | $19.2m |
| Revenue growth | 201.6% | -1.5% |
| Net income | −$68.2m | −$2.0m |
| Operating margin | — | — |
| Net margin | -3220.4% | -10.6% |
| Return on equity | — | -44.4% |
| Free cash flow | −$25.3m | −$1.6m |
| Cash | — | $2.3m |
| Total debt | $275,000 | $0 |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $8.6m | $4.7m |
| Price vs our value range | — | — |
| Moat score | 8 (Weak) | 30 (Weak) |
| Insider trades, 12 months | 9 buys, 0 sales | 0 buys, 3 sales |